{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:00:12Z","timestamp":1790532012856,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12013-020-00952-z","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T09:06:42Z","timestamp":1604048802000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Icaritin Inhibits Skin Fibrosis through Regulating AMPK and Wnt\/\u03b2-catenin Signaling"],"prefix":"10.1007","volume":"79","author":[{"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhen","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-9163","authenticated-orcid":false,"given":"Jinfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"952_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","volume":"53","author":"C Ferreli","year":"2017","unstructured":"Ferreli, C., Gasparini, G., & Parodi, A., et al. (2017). Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clinical Reviews in Allergy and Immunology, 53, 306\u2013336.","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"952_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41584-019-0184-z","volume":"15","author":"ER Volkmann","year":"2019","unstructured":"Volkmann, E. R., & Varga, J. (2019). Emerging targets of disease-modifying therapy for systemic sclerosis. Nature Reviews Rheumatology, 15, 208\u2013224.","journal-title":"Nature Reviews Rheumatology"},{"key":"952_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.trsl.2019.02.010","volume":"209","author":"B Korman","year":"2019","unstructured":"Korman, B. (2019). Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis. Translational Research, 209, 77\u201389.","journal-title":"Translational Research"},{"key":"952_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5301\/jsrd.5000240","volume":"2","author":"SM Garrett","year":"2017","unstructured":"Garrett, S. M., Baker Frost, D., & Feghali-Bostwick, C. (2017). The mighty fibroblast and its utility in scleroderma research. Journal of Scleroderma Related Disorders, 2, 69\u2013134.","journal-title":"Journal of Scleroderma Related Disorders"},{"key":"952_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.31138\/mjr.30.1.33","volume":"30","author":"D Daoussis","year":"2019","unstructured":"Daoussis, D., & Liossis, S.-N. (2019). Treatment of systemic sclerosis associated fibrotic manifestations: current options and future directions. Mediterranean Journal of Rheumatology, 30, 33\u201337.","journal-title":"Mediterranean Journal of Rheumatology"},{"key":"952_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13020-018-0175-z","volume":"13","author":"Q Wang","year":"2018","unstructured":"Wang, Q., Zang, W., & Li, H., et al. (2018). Wenyang Huazhuo Tongluo formula inhibits fibrosis via suppressing Wnt\/\u03b2-catenin signaling pathway in a Bleomycin-induced systemic sclerosis mouse model. Chinese Medicine, 13, 17\u201317.","journal-title":"Chinese Medicine"},{"key":"952_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.biopha.2018.12.016","volume":"110","author":"Q Liu","year":"2019","unstructured":"Liu, Q., Lu, J., & Lin, J., et al. (2019). Salvianolic acid B attenuates experimental skin fibrosis of systemic sclerosis. Biomedicine and Pharmacotherapy, 110, 546\u2013553.","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"952_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1472-6882-14-224","volume":"14","author":"T Wu","year":"2014","unstructured":"Wu, T., Chu, H., & Tu, W., et al. (2014). Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis. BMC Complementary and Alternative Medicine, 14, 224\u2013224.","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"952_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3736\/jcim20070510","volume":"5","author":"X-n Yan","year":"2007","unstructured":"Yan, X.-n., Feng, J., Li, W.-b., Cui, R., & Shi, B.-j. (2007). Effects of Wenyang Chubi Decoction on connective tissue growth factor and collagen-I in a mouse model of scleroderma. Zhong Xi Yi Jie He Xue Bao, 5, 526\u2013530.","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"952_CR10","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.3390\/molecules15117861","volume":"15","author":"SC Sze","year":"2010","unstructured":"Sze, S. C., Tong, Y., Ng, T. B., Cheng, C. L., & Cheung, H. P. (2010). Herba Epimedii: anti-oxidative properties and its medical implications. Molecules, 15, 7861\u20137870.","journal-title":"Molecules"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s11095-008-9602-7","volume":"25","author":"Y Chen","year":"2008","unstructured":"Chen, Y., Zhao, Y. H., Jia, X. B., & Hu, M. (2008). Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai (Yin Yanghuo). Pharmaceutical Research, 25, 2190\u20132199.","journal-title":"Pharmaceutical Research"},{"key":"952_CR12","first-page":"1","volume":"60","author":"H Wu","year":"2003","unstructured":"Wu, H., Lien, E. J., & Lien, L. L. (2003). Chemical and pharmacological investigations of Epimedium species: a survey. Progress in Drug Research, 60, 1\u201357.","journal-title":"Progress in Drug Research"},{"key":"952_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jep.2011.06.030","volume":"137","author":"J Li","year":"2011","unstructured":"Li, J., Liu, P., & Zhang, R., et al. (2011). Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. Journal of Ethnopharmacology, 137, 714\u2013723.","journal-title":"Journal of Ethnopharmacology"},{"key":"952_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jep.2005.02.036","volume":"100","author":"SY Chor","year":"2005","unstructured":"Chor, S. Y., Hui, A. Y., & To, K. F., et al. (2005). Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell. Journal of Ethnopharmacology, 100, 180\u2013186.","journal-title":"Journal of Ethnopharmacology"},{"key":"952_CR15","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1681\/ASN.2016070811","volume":"28","author":"Z Li","year":"2017","unstructured":"Li, Z., Zhou, L., & Wang, Y., et al. (2017). (Pro)renin Receptor Is an Amplifier of Wnt\/beta-Catenin Signaling in Kidney Injury and Fibrosis. Journal of the American Society of Nephrology, 28, 2393\u20132408.","journal-title":"Journal of the American Society of Nephrology"},{"key":"952_CR16","first-page":"1413","volume":"38","author":"P Blyszczuk","year":"2017","unstructured":"Blyszczuk, P., M\u00fcller-Edenborn, B., & Valenta, T., et al. (2017). Transforming growth factor-beta-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis. European Heart Journal, 38, 1413\u20131425.","journal-title":"European Heart Journal"},{"key":"952_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1164\/rccm.201401-0079OC","volume":"190","author":"AP Lam","year":"2014","unstructured":"Lam, A. P., Herazo-Maya, J. D., & Sennello, J. A., et al. (2014). Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 190, 185\u2013195.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"952_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.33549\/physiolres.932289","volume":"61","author":"Y Guo","year":"2012","unstructured":"Guo, Y., Xiao, L., Sun, L., & Liu, F. (2012). Wnt\/beta-catenin signaling: a promising new target for fibrosis diseases. Physiological Research, 61, 337\u2013346.","journal-title":"Physiological Research"},{"key":"952_CR19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1136\/annrheumdis-2012-202544","volume":"72","author":"C Beyer","year":"2013","unstructured":"Beyer, C., Reichert, H., & Akan, H., et al. (2013). Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Annals of the Rheumatic Diseases, 72, 1255\u20131258.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"952_CR20","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/art.34424","volume":"64","author":"J Wei","year":"2012","unstructured":"Wei, J., Fang, F., & Lam, A. P., et al. (2012). Wnt\/beta-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells. Arthritis and Rheumatology, 64, 2734\u20132745.","journal-title":"Arthritis and Rheumatology"},{"key":"952_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/annrheumdis-2011-200568","volume":"71","author":"C Beyer","year":"2012","unstructured":"Beyer, C., Schramm, A., & Akhmetshina, A., et al. (2012). beta-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis. Annals of the Rheumatic Diseases, 71, 761\u2013767.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"952_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","volume":"66","author":"D Garcia","year":"2017","unstructured":"Garcia, D., & Shaw, R. J. (2017). AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Molecular Cell, 66, 789\u2013800.","journal-title":"Molecular Cell"},{"key":"952_CR23","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1096\/fj.201701078R","volume":"32","author":"P Zhang","year":"2018","unstructured":"Zhang, P., Song, Y., & Sun, Y., et al. (2018). AMPK\/GSK3beta\/beta-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming. FASEB Journal, 32, 3924\u20133935.","journal-title":"FASEB Journal"},{"key":"952_CR24","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/or.2015.4519","volume":"35","author":"SY Park","year":"2016","unstructured":"Park, S. Y., Lee, Y.-K., Kim, H. J., Park, O. J., & Kim, Y. M. (2016). AMPK interacts with \u03b2-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment. Oncology Reports, 35, 1566\u20131572.","journal-title":"Oncology Reports"},{"key":"952_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejphar.2010.03.010","volume":"636","author":"D Lu","year":"2010","unstructured":"Lu, D., & Carson, D. A. (2010). Repression of beta-catenin signaling by PPAR gamma ligands. European Journal of Pharmacology, 636, 198\u2013202.","journal-title":"European Journal of Pharmacology"},{"key":"952_CR26","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1128\/MCB.00441-06","volume":"26","author":"J Liu","year":"2006","unstructured":"Liu, J., Wand, H., Zuo, Y., & Farmer, S. R. (2006). Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Molecular and Cellular Biology, 26, 5827\u20135837.","journal-title":"Molecular and Cellular Biology"},{"key":"952_CR27","first-page":"29","volume":"33","author":"Y Li","year":"2015","unstructured":"Li, Y., Zhao, T., Li, H., & Li, T. (2015). Analysis on traditional Chinese medicine\u2019s medication rule in prescriptions for the scleroderma based on data mining. Medical Research and Education, 33, 29\u201334+41.","journal-title":"Medical Research and Education"},{"key":"952_CR28","first-page":"2387","volume":"40","author":"J Li","year":"2014","unstructured":"Li, J., Ding, M., & Mou, P., et al. (2014). Effects of asiaticoside on proliferation, collagen synthesis and TGF-\u03b21 secretion of fibroblasts inpatients with systemic sclerosis. Jiangsu Medical Journal, 40, 2387\u20132389.","journal-title":"Jiangsu Medical Journal"},{"key":"952_CR29","first-page":"785","volume":"37","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Gu, F., & Wang, Y. (2017). Clinical study of total glucosides of paeony for adjuvant therapy of systemic sclerosis. Chinese Journal of Integrated Traditional and Western Medicine, 37, 785\u2013788.","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"key":"952_CR30","doi-asserted-by":"publisher","first-page":"G739","DOI":"10.1152\/ajpgi.00432.2010","volume":"301","author":"MS Sozio","year":"2011","unstructured":"Sozio, M. S., Lu, C., & Zeng, Y. (2011). Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells. American Journal of Physiology - Gastrointestinal and Liver Physiology, 301, G739\u2013G747.","journal-title":"American Journal of Physiology - Gastrointestinal and Liver Physiology"},{"key":"952_CR31","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.bcp.2006.03.005","volume":"71","author":"TD King","year":"2006","unstructured":"King, T. D., Song, L., & Jope, R. S. (2006). AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. Biochemical Pharmacology, 71, 1637\u20131647.","journal-title":"Biochemical Pharmacology"},{"key":"952_CR32","doi-asserted-by":"publisher","first-page":"51251","DOI":"10.18632\/oncotarget.9984","volume":"7","author":"J Wu","year":"2016","unstructured":"Wu, J., Du, J., & Fu, X. (2016). Iciartin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R\/STAT3 signaling. Oncotarget, 7, 51251\u201351269.","journal-title":"Oncotarget"},{"key":"952_CR33","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C. P., & Khanna, D. (2017). Systemic sclerosis. The Lancet, 390, 1685\u20131699.","journal-title":"The Lancet"},{"key":"952_CR34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/annrheumdis-2019-215066","volume":"78","author":"R Liang","year":"2019","unstructured":"Liang, R., Kagwiria, R., & Zehender, A., et al. (2019). Acyltransferase skinny hedgehog regulates TGFbeta-dependent fibroblast activation in SSc. Annals of the Rheumatic Diseases, 78, 1269\u20131273.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"952_CR35","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/ard.2010.134742","volume":"70","author":"C Dees","year":"2011","unstructured":"Dees, C., Tomcik, M., & Zerr, P., et al. (2011). Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis. Annals of the Rheumatic Diseases, 70, 1304\u20131310.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"952_CR36","doi-asserted-by":"publisher","first-page":"172794","DOI":"10.1016\/j.ejphar.2019.172794","volume":"865","author":"Y Xu","year":"2019","unstructured":"Xu, Y., Li, L., & Tang, J., et al. (2019). Icariin promotes osteogenic differentiation by suppressing Notch signaling. European Journal of Pharmacology, 865, 172794.","journal-title":"European Journal of Pharmacology"},{"key":"952_CR37","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3389\/fimmu.2018.01611","volume":"9","author":"MJ Park","year":"2018","unstructured":"Park, M. J., Moon, S.-J., & Lee, E.-J., et al. (2018). IL-1-IL-17 signaling axis contributes to fibrosis and inflammation in two different murine models of systemic sclerosis. Frontiers in Immunology, 9, 1611.","journal-title":"Frontiers in Immunology"},{"key":"952_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1515\/rjim-2017-0027","volume":"55","author":"P Balanescu","year":"2017","unstructured":"Balanescu, P., Balanescu, E., & Balanescu, A. (2017). IL-17 and Th17 cells in systemic sclerosis: a comprehensive review. Romanian Journal of Internal Medicine, 55, 198\u2013204.","journal-title":"Romanian Journal of Internal Medicine"},{"key":"952_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2015.11.006","volume":"162","author":"J Liao","year":"2016","unstructured":"Liao, J., Liu, Y., & Wu, H., et al. (2016). The role of icaritin in regulating Foxp3\/IL17a balance in systemic lupus erythematosus and its effects on the treatment of MRL\/lpr mice. Clinical Immunology, 162, 74\u201383.","journal-title":"Clinical Immunology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-020-00952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-020-00952-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-020-00952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T19:18:40Z","timestamp":1620674320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-020-00952-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1007\/s12013-020-00952-z","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"5 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}